How big is the Middle East & Africa Glaucoma Therapeutics Market?

The Middle East & Africa Glaucoma Therapeutics Market is valued at US$ 518.94 Million in 2023, it is projected to reach US$ 638.34 Million by 2031.

What is the CAGR for Middle East & Africa Glaucoma Therapeutics Market by (2023 - 2031)?

As per our report Middle East & Africa Glaucoma Therapeutics Market, the market size is valued at US$ 518.94 Million in 2023, projecting it to reach US$ 638.34 Million by 2031. This translates to a CAGR of approximately 2.6% during the forecast period.

What segments are covered in this report?

The Middle East & Africa Glaucoma Therapeutics Market report typically cover these key segments- 药物类别（β受体阻滞剂、α肾上腺素能激动剂、前列腺素类似物、碳酸酐酶抑制剂、复方药物）适应症（开角型青光眼、闭角型青光眼）分销渠道（医院药房、零售药房、网上药房）

What is the historic period, base year, and forecast period taken for Middle East & Africa Glaucoma Therapeutics Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Glaucoma Therapeutics Market report: 2025-2031 2023 2021-2023

Who are the major players in Middle East & Africa Glaucoma Therapeutics Market?

The Middle East & Africa Glaucoma Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Alcon AG ; AbbVie Inc ; Bausch & Lomb Inc ; Viatris Inc ; Novartis AG ; Sun Pharmaceutical Industries Ltd ; Teva Pharmaceuticals Industries Ltd ; Thea Pharma Inc ; Santen Pharmaceutical Co., Ltd

Who should buy this report?

The Middle East & Africa Glaucoma Therapeutics Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the Middle East & Africa Glaucoma Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.

中东和非洲青光眼治疗市场（主要地区、市场参与者、规模和份额）预测至 2031 年

2023 年中东和非洲青光眼治疗市场价值为 5.1894 亿美元，预计到 2031 年将达到 6.3834 亿美元；预计 2023 年至 2031 年的复合年增长率为 2.6%。

新型药物输送方法的开发推动中东和非洲青光眼治疗市场

治疗青光眼最常见的方法之一是使用眼药水降低眼压。尽管如此，人们越来越关注开发具有增强稳定性、更长循环时间和靶向结合特性的改良配方，未来可能会为市场带来新的产品。使用具有合适结构和优异结合能力的纳米颗粒有助于提高药物的生物利用度和疗效。与传统眼药水相比，缓释 (SR) 植入物和其他创新药物输送系统有助于提高患者的依从性并减少副作用。多家公司正在开发 SR 药物输送系统，作为局部给药的替代方案，以期克服原发性开角型青光眼 (POAG) 治疗相关的障碍。根据 2022 年 PubMed Central 发表的一篇文章，FDA 批准的唯一一种 POAG SR 疗法是艾尔建公司的比马前列素 SR (DurystaTM)。其他正在研究的 SR 疗法包括比马前列素眼环 (Allergan)、iDose (Glaukos Corporation)、ENV515 (Envisia Therapeutics)、OTX-TP (Ocular Therapeutix)、OTX-TIC (Ocular Therapeutix) 和拉坦前列素游离酸 SR (PolyActiva)。POAG 管理中的 SR 药物输送技术可能会改变治疗模式并显著改善疗效。因此，开发新型药物输送方法很可能仍将是青光眼治疗市场的一个关键趋势。

中东和非洲青光眼治疗市场概览

中东和非洲青光眼治疗市场分为阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区。该地区老年人口中青光眼的患病率不断上升，以及政府为提高对该疾病的认识而采取的举措不断增多，推动了中东和非洲青光眼治疗市场的增长。根据 IAPB 在 2020 年 3 月发表的一篇文章，由眼球引流异常引起的先天性青光眼是沙特阿拉伯儿童失明的主要原因。据估计，该国约有 8,000 名儿童患有功能性低视力。儿童通常病情严重，需要多次手术和终身医疗护理，给患者及其家庭带来沉重的社会和经济负担。该地区的各种研究机构都在致力于开发和实施青光眼治疗疗法。例如，2021年6月发表在《JBI证据实施》上的一篇文章，对一个试点项目的实施情况进行了检查，旨在评估其对循证标准的遵守情况，并在沙特阿拉伯利雅得的一家专科眼科中心引入了一项修订后的临床实践指南（CPG），用于治疗原发性开角型青光眼（POAG）患者。评估表明，审核和反馈是改变沙特阿拉伯医院青光眼治疗实践的有效工具。这意味着该项目的实施可以推广，以促进循证眼科实践，并可能提高质量和一致性，优化患者护理。因此，该国青光眼治疗研发活动的增加可能会在预测期内支持市场增长。

中东和非洲青光眼治疗市场收入及预测至2031年（百万美元）

中东和非洲青光眼治疗市场细分

中东和非洲青光眼治疗市场按药物类别、适应症、分销渠道和国家/地区分类。

根据药物类别，中东和非洲青光眼治疗市场细分为β受体阻滞剂、α肾上腺素能激动剂、前列腺素类似物、碳酸酐酶抑制剂、复方药物等。前列腺素类似物细分市场在2023年占据最大市场份额。

按适应症分类，中东和非洲青光眼治疗市场分为开角型青光眼、闭角型青光眼等。 2023 年，开角型青光眼细分市场占有最大市场份额。

按分销渠道划分，中东和非洲青光眼治疗市场分为医院药房、零售药房和网上药房。2023 年，医院药房细分市场占有最大市场份额。

按国家划分，中东和非洲青光眼治疗市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。2023 年，沙特阿拉伯占据了中东和非洲青光眼治疗市场的主导份额。

爱尔康公司、艾伯维公司、博士伦公司、Viatris 公司、诺华公司、太阳制药工业有限公司、梯瓦制药工业有限公司、Thea Pharma 公司和参天制药株式会社是中东和非洲青光眼治疗市场的领先公司。

Middle East & Africa Glaucoma Therapeutics Strategic Insights

Strategic insights for Middle East & Africa Glaucoma Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-glaucoma-therapeutics-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Glaucoma Therapeutics Report Scope

Report Attribute	Details
Market size in 2023	US$ 518.94 Million
Market Size by 2031	US$ 638.34 Million
Global CAGR (2023 - 2031)	2.6%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 药物类别（β受体阻滞剂、α肾上腺素能激动剂、前列腺素类似物、碳酸酐酶抑制剂、复方药物） By 适应症（开角型青光眼、闭角型青光眼） By 分销渠道（医院药房、零售药房、网上药房）
Regions and Countries Covered	中东和非洲（南非、沙特阿拉伯、阿联酋、中东和非洲其他地区）中东和非洲（南非、沙特阿拉伯、阿联酋、中东和非洲其他地区）
Market leaders and key company profiles	Alcon AG AbbVie Inc Bausch & Lomb Inc Viatris Inc Novartis AG Sun Pharmaceutical Industries Ltd Teva Pharmaceuticals Industries Ltd Thea Pharma Inc Santen Pharmaceutical Co., Ltd

Get more information on this report

Middle East & Africa Glaucoma Therapeutics Regional Insights

The regional scope of Middle East & Africa Glaucoma Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.